Clinical Trials
8 trialsNCT05810350 2023-04-13
Aumolertinib Combined Intrathecal Chemotherapy for Leptomeningeal Metastasis From EGFR-Mutated NSCLC and Prognostic Value of Dynamic Changes in cfDNA Profiles
Three Gorges Hospital of Chongqing University
Phase 2 Unknown
NCT04211090 2022-11-16
CAP-BRAIN
Sun Yat-sen University
Phase 2 Unknown
NCT05305885 2022-09-30
Intra-pemetrexed Alone or Combined With Concurrent Radiotherapy for Leptomeningeal Metastasis
The First Hospital of Jilin University
Phase NA Unknown
NCT05459441 2022-07-15
Efficacy and Safety Evaluation of Percutaneous Ommaya Capsule Injection of Autologous Bi-dimensional Specific T Cells in the Treatment of Glioma and in Combination With Pemetrexed in the Treatment of Brain/Meningeal Metastases
Shanghai Pudong Hospital
Phase EARLY_PHASE1 Unknown
NCT01951469 2022-03-08
Gefitinib With or Without Chemotherapy in Brain Metastases From Non-small Cell Lung Cancer
Sun Yat-sen University
Phase 3 Unknown
NCT00276783 2020-03-05
Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases
Northwestern University
Phase 2 Unknown
NCT02284490 2014-11-06
High-dose Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases
Shandong Cancer Hospital and Institute
Phase 2 Unknown
NCT01985451 2013-11-15
Pemetrexed and Temozolomide in Treating Patients With Relapsed Primary Central Nervous System Lymphoma （PCNSL）
Shandong Cancer Hospital and Institute
Phase 2 Unknown